Cite
HARVARD Citation
Megaro, G. et al. (2022). Long‐term response to crizotinib in a 17‐year‐old boy with treatment‐naïve ALK‐positive non‐small‐cell lung cancer. Cancer reports. 5 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Megaro, G. et al. (2022). Long‐term response to crizotinib in a 17‐year‐old boy with treatment‐naïve ALK‐positive non‐small‐cell lung cancer. Cancer reports. 5 (3), p. n/a. [Online].